Research
Doggybone DNA vaccine provides long lasting immunity against SARS CoV 2 than Covaxin
Nature ·
The Brief
- A study reports that the Doggybone DNA vaccine provides longer-lasting immunity against SARS-CoV-2 than Covaxin.
- The only source is a Nature subject-feed entry with no summary, so methods and effect sizes are not available.
Why it matters
Comparative durability data for a DNA vaccine against SARS-CoV-2 could inform vaccine development, but the available source gives no details beyond the headline.
Who’s affected
- researchers in immunology and vaccinology
- readers following COVID-19 vaccine development
- #vaccines
- #dna vaccine
- #sars-cov-2
- #covid-19
- #immunology
Timeline
Study listed in Nature Biological sciences subject feed
Biological sciences : nature.com subject feeds
Doggybone DNA vaccine provides long lasting immunity against SARS CoV 2 than Covaxin